2.4.1.219 Diabetes Mellitus https://pubmed.ncbi.nlm.nih.gov/29026604/ Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study. causal interaction 3 2.4.1.219 Diabetes Mellitus https://pubmed.ncbi.nlm.nih.gov/23657005/ Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study. diagnostic usage 2 2.4.1.219 Diabetes Mellitus https://pubmed.ncbi.nlm.nih.gov/22098444/ Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial. diagnostic usage 1 2.4.1.219 Diabetes Mellitus https://pubmed.ncbi.nlm.nih.gov/23657005/ Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study. therapeutic application 2 2.4.1.219 Diabetes Mellitus https://pubmed.ncbi.nlm.nih.gov/29026604/ Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study. therapeutic application 4 2.4.1.219 Diabetes Mellitus https://pubmed.ncbi.nlm.nih.gov/22098444/ Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial. therapeutic application 2 2.4.1.219 Diabetes Mellitus https://pubmed.ncbi.nlm.nih.gov/23657005/ Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study. ongoing research 3 2.4.1.219 Diabetes Mellitus https://pubmed.ncbi.nlm.nih.gov/29026604/ Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study. ongoing research 2 2.4.1.219 Diabetes Mellitus https://pubmed.ncbi.nlm.nih.gov/22098444/ Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial. ongoing research 3 2.4.1.219 Diabetes Mellitus https://pubmed.ncbi.nlm.nih.gov/23657005/ Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study. unassigned - 2.4.1.219 Diabetes Mellitus https://pubmed.ncbi.nlm.nih.gov/22098444/ Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial. unassigned - 2.4.1.219 Diabetes Mellitus https://pubmed.ncbi.nlm.nih.gov/29026604/ Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study. unassigned - 2.4.1.219 Diabetes Mellitus, Type 2 https://pubmed.ncbi.nlm.nih.gov/29026604/ Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study. causal interaction 3 2.4.1.219 Diabetes Mellitus, Type 2 https://pubmed.ncbi.nlm.nih.gov/22098444/ Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial. diagnostic usage 1 2.4.1.219 Diabetes Mellitus, Type 2 https://pubmed.ncbi.nlm.nih.gov/23657005/ Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study. diagnostic usage 2 2.4.1.219 Diabetes Mellitus, Type 2 https://pubmed.ncbi.nlm.nih.gov/22098444/ Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial. therapeutic application 2 2.4.1.219 Diabetes Mellitus, Type 2 https://pubmed.ncbi.nlm.nih.gov/23657005/ Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study. therapeutic application 2 2.4.1.219 Diabetes Mellitus, Type 2 https://pubmed.ncbi.nlm.nih.gov/29026604/ Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study. therapeutic application 4 2.4.1.219 Diabetes Mellitus, Type 2 https://pubmed.ncbi.nlm.nih.gov/22098444/ Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial. ongoing research 3 2.4.1.219 Diabetes Mellitus, Type 2 https://pubmed.ncbi.nlm.nih.gov/23657005/ Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study. ongoing research 3 2.4.1.219 Diabetes Mellitus, Type 2 https://pubmed.ncbi.nlm.nih.gov/29026604/ Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study. ongoing research 2 2.4.1.219 Diabetes Mellitus, Type 2 https://pubmed.ncbi.nlm.nih.gov/22098444/ Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial. unassigned - 2.4.1.219 Diabetes Mellitus, Type 2 https://pubmed.ncbi.nlm.nih.gov/23657005/ Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study. unassigned - 2.4.1.219 Diabetes Mellitus, Type 2 https://pubmed.ncbi.nlm.nih.gov/29026604/ Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study. unassigned - 2.4.1.219 Gaucher Disease https://pubmed.ncbi.nlm.nih.gov/33361282/ Human glucocerebrosidase mediates formation of xylosyl-cholesterol by ?-xylosidase and transxylosidase reactions. causal interaction 4 2.4.1.219 Gaucher Disease https://pubmed.ncbi.nlm.nih.gov/33361282/ Human glucocerebrosidase mediates formation of xylosyl-cholesterol by ?-xylosidase and transxylosidase reactions. unassigned - 2.4.1.219 Hyperglycemia https://pubmed.ncbi.nlm.nih.gov/20165914/ Supplementing transglucosidase with a high-fiber diet for prevention of postprandial hyperglycemia in streptozotocin-induced diabetic dogs. therapeutic application 2 2.4.1.219 Hyperglycemia https://pubmed.ncbi.nlm.nih.gov/20165914/ Supplementing transglucosidase with a high-fiber diet for prevention of postprandial hyperglycemia in streptozotocin-induced diabetic dogs. unassigned - 2.4.1.219 Movement Disorders https://pubmed.ncbi.nlm.nih.gov/29026604/ Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study. causal interaction 3 2.4.1.219 Movement Disorders https://pubmed.ncbi.nlm.nih.gov/29026604/ Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study. therapeutic application 4 2.4.1.219 Movement Disorders https://pubmed.ncbi.nlm.nih.gov/29026604/ Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study. ongoing research 2 2.4.1.219 Movement Disorders https://pubmed.ncbi.nlm.nih.gov/29026604/ Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study. unassigned -